Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201600 · ClinicalTrials.gov registry record
Glucose Variability and Cognition in Prediabetes
A clinical trial of Depression and Aging, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT04201600 is a study of Depression and Aging that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 30 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04201600, a study of Depression and Aging, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitoring System (CGMS)
Study Locations (1)
Maryland
- Baltimore VA Geriatric Research Education and Clinical Center (GRECC) - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04201600
The ClinicalTrials.gov registry entry for NCT04201600 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitoring System (CGMS) is the first listed.
NCT04201600 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04201600 about?
NCT04201600 is a clinical study titled "Glucose Variability and Cognition in Prediabetes". This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.
What is the current status of trial NCT04201600?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2022-03-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04201600 study?
This clinical trial studies the following conditions: Depression, Aging, PreDiabetes, Cognitive Decline, Glucose Metabolism Disorders (Including Diabetes Mellitus).
What interventions are being tested in trial NCT04201600?
The interventions under investigation include: Continuous Glucose Monitoring System (CGMS) (DEVICE).
Who is sponsoring clinical trial NCT04201600?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04201600 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.